Choriogonadotropin alpha Other names: human chorionic gonadotrophin (hCG) Human chorionic gonadotropin

Active ingredient description

The principal pharmacodynamic activity in women is oocyte meiosis resumption, follicular rupture (ovulation), corpus luteum formation and production of progesterone and estradiol by the corpus luteum.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
G03GA08 Choriogonadotropin alfa G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03G Gonadotropins and other ovulation stimulants → G03GA Gonadotropins
Discover more medicines within G03GA08

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
OVITRELLE Solution for injection in pre-filled syringe European Medicines Agency (EU) MPI, EU: SmPC
OVIDREL Solution for injection FDA, National Drug Code (US) MPI, US: SPL/Old

3D molecular structure

3D representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 177073-44-8
DrugBank Drug: DB00097
RxNorm Ingredient: 283550
UNII Identifier: 6413W06WR3
CHORIOGONADOTROPIN ALFA

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.